LIFE SCIENCES & Health

At the heart of Health Valley

The canton of Vaud is home to a very significant number of high-quality infrastructures as well as knowledge and expertise in the field of life sciences. Indeed, the region is often referred to as "Health Valley."

The University Hospital of the Canton of Vaud (CHUV) plays a central role in the sectors of medical care, research, and training. It develops ambitious projects such as "Neurotech,” a platform that is unique in Europe and which is dedicated to the evaluation of the impact of new technologies in the field of neurosciences. The department of oncology, led by Professor George Coukos, conducts renowned international work into cancer research, while Agora, a center devoted to cancer research, will be inaugurated in 2018 and will feature 300 researchers and doctors.

The region has positioned itself at the forefront of research in these domains, and also in the fields of neurosciences, immunology, nutrition, and cardiovascular diseases. Innovative disciplines such as bioinformatics, medical imaging, and robotic surgery are also developing rapidly.

The canton has almost 400 businesses and as many laboratories active in life sciences, and the ecosystem in Vaud is continually being enriched by the creation of start-ups. In 2016, new companies in Health Valley attracted 7.4% of global venture capital investment in the sector.

Around 60 companies from abroad, including Medtronic and Becton Dickinson, have chosen to develop their industrial activities and services in the region.

Find out more about Life Sciences in Vaud

Our success stories

Parker Hannifin

For over a century, Parker Hannifin has contributed to technological advances that create a better world. With its Europe, Middle East & Africa (EMEA) headquarters in the Canton of Vaud, the US conglomerate offers solutions in a broad range of markets and industrial applications.

Merck

Merck develops advanced treatments in the canton of Vaud. Now, the German multinational plans to expand its production capacity in the region.

Incyte

Incyte Biosciences International Sàrl, headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with leading-edge medicines. It is working on new medicines to advance the treatment of various forms of acute and chronic leukemia, lung cancer and other difficult-to-treat cancers.

News and events

10/28/2021

Tech Tour Alpine 2021

With 8 years of history, the Tech Tour Alpine Programme is focused on helping innovative technology companies in the Alpine region to exchange contacts, secure growth, and investment by working together with peers, experts and active investors in building lasting business co-operations.

Lausanne

Free tickets for PME & Startups

7/19/2021

A wireless remote control to solve erectile dysfunction

Comphya designed the first implantable neurostimulator that allows patients with erectile dysfunction to activate the nerve responsible for penile erections using a wireless remote control.

7/6/2021

GE Healthcare and SOPHiA GENETICS to collaborate

GE Healthcare and SOPHiA GENETICS today announced that they have signed a letter of intent to collaborate on advancing cancer care, with the goal of better targeting and matching treatments to each patient’s genomic profile and cancer type.